Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients

被引:42
作者
Bock, Merete [1 ]
Heijnen, Ingmar [2 ]
Trendelenburg, Marten [1 ]
机构
[1] Univ Basel Hosp, Div Internal Med, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Lab Med, Div Med Immunol, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEREDITARY C1Q DEFICIENCY; DISEASE-ACTIVITY; IGG AUTOANTIBODIES; PREDICTIVE-VALUE; NEPHRITIS; COMPLEMENT; HYPOCOMPLEMENTEMIA; MANIFESTATIONS; IMMUNOLOGY;
D O I
10.1371/journal.pone.0123572
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
In cross-sectional studies autoantibodies against complement C1q (anti-C1q) were found to be highly associated with active lupus nephritis. The aim of this retrospective study was to determine the value of anti-C1q as follow-up marker of disease activity and renal involvement in patients with systemic lupus erythematosus (SLE). Fifty-two patients with SLE and a minimum of three anti-C1q measurements during follow-up were analyzed. Anti-C1q levels correlated with global disease activity scores. In subgroup analyses, patients without renal involvement did not show a significant correlation between anti-C1q levels and disease activity. In contrast, in patients with renal involvement, anti-C1q levels correlated well with global disease activity. In addition, a positive correlation with the urine protein-to-creatinine ratio and anti-dsDNA antibody levels as well as a negative correlation with complement levels was observed. Anti-C1q antibodies were found to strongly correlate with parameters of SLE disease activity during follow-up, in particular with regard to renal involvement.
引用
收藏
页数:11
相关论文
共 33 条
[1]
Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers [J].
Akhter, E. ;
Burlingame, R. W. ;
Seaman, A. L. ;
Magder, L. ;
Petri, M. .
LUPUS, 2011, 20 (12) :1267-1274
[2]
DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[3]
BOWNESS P, 1994, Q J MED, V87, P455
[4]
Cameron JS, 1999, J AM SOC NEPHROL, V10, P413
[5]
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Mejía, JC ;
Aydintug, AC ;
Chwalinska-Sadowska, H ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Valen, M ;
Mathieu, A ;
Houssiau, FD ;
Caro, N ;
Alba, P ;
Ramos-Casals, M ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 2003, 82 (05) :299-308
[6]
CHANGES IN ANTIBODIES TO C1Q PREDICT RENAL RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
COREMANS, IEM ;
SPRONK, PE ;
BOOTSMA, H ;
DAHA, MR ;
VANDERVOORT, EAM ;
KATER, L ;
BREEDVELD, FC ;
KALLENBERG, CGM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (04) :595-601
[7]
Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus [J].
FremeauxBacchi, V ;
Weiss, L ;
Demouchy, C ;
Blouin, J ;
Kazatchkine, MD .
LUPUS, 1996, 5 (03) :216-220
[8]
Autoantibodies and other biomarkers - pathological consequences (1) [J].
Giles, I. ;
Putterman, C. .
LUPUS, 2008, 17 (03) :241-246
[9]
Measurement of Autoantibodies in Pediatric-Onset Systemic Lupus Erythematosus and Their Relationship with Disease-Associated Manifestations [J].
Gilliam, Brooke E. ;
Ombrello, Amanda K. ;
Burlingame, Rufus W. ;
Pepmueller, Peri H. ;
Moore, Terry L. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 41 (06) :840-848
[10]
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725